InMed Pharmaceuticals a publicly traded Canadian canna biopharmaceutical company CEO Eric Adams speak with Dan Humiston about their company's Biosynthesis research and their development of three canna drugs in their pipeline.
https://podconx.com/guests/eric-adams
MJBulls - https://podconx.com/podcasts/raising-cannabis-capital
Dan Humiston - https://www.linkedin.com/in/humiston/
Sound Design - Jamie Humiston - https://www.linkedin.com/in/jamie-humiston-91718b1b3/
Recorded on Squadcast - https://squadcast.fm/
